These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6731645)

  • 1. Serial dexamethasone suppression tests in male chronic schizophrenic patients.
    Myers ED
    Am J Psychiatry; 1984 Jul; 141(7):904-5. PubMed ID: 6731645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal dexamethasone suppression test results in chronic schizophrenic patients.
    Dewan MJ; Pandurangi AK; Boucher ML; Levy BF; Major LF
    Am J Psychiatry; 1982 Nov; 139(11):1501-3. PubMed ID: 7137407
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test.
    Banki CM; Arató M; Rihmer Z
    Neuropsychobiology; 1984; 11(3):174-7. PubMed ID: 6472604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in newly hospitalized schizophrenic patients.
    Herz MI; Fava GA; Molnar G; Edwards L
    Am J Psychiatry; 1985 Jan; 142(1):127-9. PubMed ID: 3966575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between dexamethasone nonsuppression and negative symptoms in schizophrenic patients.
    Tandon R
    Acta Psychiatr Scand; 1989 Nov; 80(5):524-5. PubMed ID: 2574530
    [No Abstract]   [Full Text] [Related]  

  • 8. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ
    Am J Psychiatry; 1985 May; 142(5):659-60. PubMed ID: 3985211
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG
    J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z
    Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711
    [No Abstract]   [Full Text] [Related]  

  • 12. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA; Aldridge CR; Fahy TA; Eastment C
    Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia.
    Goldman MB; Blake L; Marks RC; Hedeker D; Luchins DJ
    Am J Psychiatry; 1993 Apr; 150(4):653-5. PubMed ID: 8465887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
    Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects.
    Monteleone P; Piccolo A; Martino M; Maj M
    Neuropsychobiology; 1994; 30(2-3):61-5. PubMed ID: 7800165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients.
    Newcomer JW; Faustman WO; Whiteford HA; Moses JA; Csernansky JG
    Biol Psychiatry; 1991 May; 29(9):855-64. PubMed ID: 2049484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
    Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
    Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in psychotic disorders.
    Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.